Psychedelic Odyssey Conference

Image

Psychedelic Odyssey Conference - All Presentations

4.0 General, 7.5 Pharmacology, 0.5 Ethics (Total 12.0 CEUs)

Learn More

Image

Psychedelic Ketamine Experiences in the Clinical Setting: Case Studies and Discussion

Lindsay Wilkinson, ND, LAc
1.5 Pharmacology CEUs

Learn More

Image

What is the Mi(gh)ter Hype of Kratom? Pharmacology, Potential Benefits and Harms of Mitragyna speciosa

Oliver Grundman, PhD
1.5 Pharmacology CEUs

Learn More

Image

Magic Mushrooms: Including the Efficacy & Safety of Oregon Psilocybin Services

Georgina Cullen-Kerney, ND, MAc
0.75 General, 0.5 Pharmacology, 0.25 Ethics (Total 1.5 CEUs)

Learn More

Image

Bringing Ayahuasca to North America: Technical and Ethical Challenges

Leanna Standish, NMD
1.0 General, 0.25 Pharmacology, 0.25 Ethics (Total 1.5 CEUs)

Learn More

Image

Microdosing Psilocybin & LSD: What We Know So Far

Erica Zelfand, ND
1.5 Pharmacology CEUs

Learn More

Image

38 Million Moments Shaping Your Epigenome: Exploring Psychedelic Healing

Candace Lewis, PhD
1.25 General, 0.25 Pharmacology (Total 1.5 CEUs)

Learn More

Image

Psychedelics: Effectors of Neuroinflammatory Programming

Austin Perlmutter, MD
1.0 General, 0.5 Pharmacology (Total 1.5 CEUs)

Learn More

Image

Clinical Ketamine Use: Considerations in Special Populations

Alicia Bigelow, ND
1.5 Pharmacology CEUs

Learn More